Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthma
Bibliographic record
Abstract
TherapeuticsJanuary 1, 2002Omalizumab reduced inhaled corticosteroid use and exacerbations in childhood allergic asthmaBruce Mazer, MD, Bruce Mazer, MDBruce Mazer, MDMeakins Christie Laboratories, Montreal, Quebec, Canada (B.M., B.M.)Meakins Christie Laboratories, Montreal, Quebec, Canada (B.M., B.M.)Search for more papers by this author, Bruce Mazer, MDMeakins Christie Laboratories, Montreal, Quebec, Canada (B.M., B.M.)Meakins Christie Laboratories, Montreal, Quebec, Canada (B.M., B.M.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/ACPJC-2002-136-1-016 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookTwitterLinkedInRedditEmail Source CitationMilgrom H, Berger W, Nayak A, et al. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001 Aug;108:e36. https://pubmed.ncbi.nlm.nih.gov/11483846References1 Busse W, Corren J, Lanier Q, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol. 2001;108:184-90. Google Scholar2 Soler M, Matz J, Townley R, et al. The anti-IgE antibody omalizumab reduces exacerbations and steroid requirements in allergic asthmatics. Eur Respir J. 2001;18:254-61. Google Scholar3 Milgrom H, Fick RB, Jr., Su JQ, et al. Treatment of allergic asthma with monoclonal anti IgE antibody. N Engl J Med. 1999;341:1966-73. Google Scholar Author, Article, and Disclosure InformationAffiliations: Meakins Christie Laboratories, Montreal, Quebec, Canada (B.M., B.M.)Meakins Christie Laboratories, Montreal, Quebec, Canada (B.M., B.M.) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails January 1, 2002Volume 136, Issue 1Page: 16KeywordsAsthmaBody weightBronchodilatorsChildrenCorticosteroid therapyDustElectrocardiographyLungsMitesPediatricsPulmonary diseasesResearch laboratoriesRespiratory system proceduresSkin testsSubcutaneous injectionsSystemic diseasesThoraxUpper respiratory tract infections ePublished: 9 March 2020 Issue Published: January 1, 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.000 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.000 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.001 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".